These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


268 related items for PubMed ID: 20207784

  • 1. Influence of HLA-DRB1 allele heterogeneity on disease risk and clinical course in a West Australian MS cohort: a high-resolution genotyping study.
    Wu JS, James I, Wei Qiu, Castley A, Christiansen FT, Carroll WM, Mastaglia FL, Kermode AG.
    Mult Scler; 2010 May; 16(5):526-32. PubMed ID: 20207784
    [Abstract] [Full Text] [Related]

  • 2. Presence of CSF oligoclonal bands (OCB) is associated with the HLA-DRB1 genotype in a West Australian multiple sclerosis cohort.
    Wu JS, Qiu W, Castley A, James I, Joseph J, Christiansen FT, Carroll WM, Mastaglia FL, Kermode AG.
    J Neurol Sci; 2010 Jan 15; 288(1-2):63-7. PubMed ID: 19879597
    [Abstract] [Full Text] [Related]

  • 3. Modifying effects of HLA-DRB1 allele interactions on age at onset of multiple sclerosis in Western Australia.
    Wu JS, Qiu W, Castley A, James I, Mastaglia FL, Christiansen FT, Carroll WM, Joseph J, Kermode AG.
    Mult Scler; 2010 Jan 15; 16(1):15-20. PubMed ID: 19995849
    [Abstract] [Full Text] [Related]

  • 4. The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population.
    Silva AM, Pereira C, Bettencourt A, Carvalho C, Couto AR, Leite MI, Marta M, Freijo M, Costa PP, Mendonça D, Monteiro L, Armas JB, Martins B.
    J Neurol Sci; 2007 Jul 15; 258(1-2):69-74. PubMed ID: 17412364
    [Abstract] [Full Text] [Related]

  • 5. HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis.
    Stankovich J, Butzkueven H, Marriott M, Chapman C, Tubridy N, Tait BD, Varney MD, Taylor BV, Foote SJ, ANZgene Consortium, Kilpatrick TJ, Rubio JP.
    Tissue Antigens; 2009 Jul 15; 74(1):17-21. PubMed ID: 19392788
    [Abstract] [Full Text] [Related]

  • 6. Sporadic inclusion body myositis: HLA-DRB1 allele interactions influence disease risk and clinical phenotype.
    Mastaglia FL, Needham M, Scott A, James I, Zilko P, Day T, Kiers L, Corbett A, Witt CS, Allcock R, Laing N, Garlepp M, Christiansen FT.
    Neuromuscul Disord; 2009 Nov 15; 19(11):763-5. PubMed ID: 19720533
    [Abstract] [Full Text] [Related]

  • 7. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.
    Barcellos LF, Sawcer S, Ramsay PP, Baranzini SE, Thomson G, Briggs F, Cree BC, Begovich AB, Villoslada P, Montalban X, Uccelli A, Savettieri G, Lincoln RR, DeLoa C, Haines JL, Pericak-Vance MA, Compston A, Hauser SL, Oksenberg JR.
    Hum Mol Genet; 2006 Sep 15; 15(18):2813-24. PubMed ID: 16905561
    [Abstract] [Full Text] [Related]

  • 8. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
    Zivadinov R, Uxa L, Bratina A, Bosco A, Srinivasaraghavan B, Minagar A, Ukmar M, Benedetto Sy, Zorzon M.
    Int Rev Neurobiol; 2007 Sep 15; 79():521-35. PubMed ID: 17531857
    [Abstract] [Full Text] [Related]

  • 9. Parent-of-origin of HLA-DRB1*1501 and age of onset of multiple sclerosis.
    Ramagopalan SV, Byrnes JK, Dyment DA, Guimond C, Handunnetthi L, Disanto G, Yee IM, Ebers GC, Sadovnick AD.
    J Hum Genet; 2009 Sep 15; 54(9):547-9. PubMed ID: 19629136
    [Abstract] [Full Text] [Related]

  • 10. HLA-DRB1 and month of birth in multiple sclerosis.
    Ramagopalan SV, Link J, Byrnes JK, Dyment DA, Giovannoni G, Hintzen RQ, Sundqvist E, Kockum I, Smestad C, Lie BA, Harbo HF, Padyukov L, Alfredsson L, Olsson T, Sadovnick AD, Hillert J, Ebers GC.
    Neurology; 2009 Dec 15; 73(24):2107-11. PubMed ID: 20018638
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Epistasis between HLA-DRB1 parental alleles in a Spanish cohort with multiple sclerosis.
    Romero-Pinel L, Pujal JM, Martínez-Yélamos S, Gubieras L, Matas E, Bau L, Torrabadella M, Azqueta C, Arbizu T.
    J Neurol Sci; 2010 Nov 15; 298(1-2):96-100. PubMed ID: 20810130
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical profile and HLA-DRB1 genotype of late onset multiple sclerosis in Western Australia.
    Qiu W, Wu JS, Castley A, James I, Joseph J, Christiansen FT, Carroll WM, Mastaglia FL, Kermode AG.
    J Clin Neurosci; 2010 Aug 15; 17(8):1009-13. PubMed ID: 20580995
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. HLA (A-B-C and -DRB1) alleles and brain MRI changes in multiple sclerosis: a longitudinal study.
    Liguori M, Healy BC, Glanz BI, Khoury SJ, Moscufo N, Weiner HL, De Jager PL, Guttmann CR.
    Genes Immun; 2011 Apr 15; 12(3):183-90. PubMed ID: 21179117
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Association of HLA-DRB1 and -DPB1 allele polymorphism with multiple sclerosis in Chinese Han population from Southern areas].
    Wu XM, Zhang KN, Wang CD, Xiong YQ, Liu Z, Qu XH, Xie XF.
    Zhonghua Yi Xue Za Zhi; 2007 Oct 23; 87(39):2741-4. PubMed ID: 18167262
    [Abstract] [Full Text] [Related]

  • 20. Mediterranean and Amerindian MHC class II alleles are associated with multiple sclerosis in Mexicans.
    Aláez C, Corona T, Ruano L, Flores H, Loyola M, Gorodezky C.
    Acta Neurol Scand; 2005 Nov 23; 112(5):317-22. PubMed ID: 16218914
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.